Medical imaging AI company Avicenna.AI today announced that it has received 510(k) clearance from the US Food and Drug Administration for its CINA-CSpine tool. Using a combination of deep learning and ...

Sales took off for an Ohio State University spinoff's AI software for planning heart surgery, once Medicare agreed to pay for ...

The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious ...

Avicenna.AI, a medical imaging AI company, has earned FDA clearance for its CINA-CSpine tool, designed to support the detection of cervical spine fractures from CT images, according to a Sept. 19 ...

T-Mobile is making a bold move into AI in 2024, partnering with OpenAI to revolutionize how it handles customer support.

Assisted Focal One procedures successfully performed at the UCLA School of MedicineFDA-cleared Unfold AI enables urologists to provide tailored, patient-specific Robotic HIFU ablation for prostate ...

The U.S. Food and Drug Administration has approved Elanco Animal Health's dermatitis treatment for dogs, the health regulator ...

Novartis’ Kisqali receives US FDA approval to reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Thursday, September 19, 2024, 13:00 Hrs [IST] Novarti ...

This summary presents key updates in the health sector. Highlights include UnitedHealth's tech unit customers adopting ...

Yet an AARP survey found that Americans older than 40 are more likely to get colonoscopies than hearing tests. Even though ...

They may be Tigrinya speakers fleeing the authoritarian Eritrean government's indefinite military service policy. Or Rohingya people escaping ethnic violence in Myanmar. But refugees navigating resett ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that DIGITIVA™, a non-invasive digital healt ...